Protara Therapeutics, Inc. (TARA) Free cash flow 2016–2025
Protara Therapeutics, Inc. (TARA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$56.5MFY2025 · since FY2016: -$24.0M → -$56.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$56.5M | -57.4% |
| FY2024 | -$35.9M | +4.6% |
| FY2023 | -$37.6M | -41.5% |
| FY2022 | -$26.6M | +24.3% |
| FY2021 | -$35.1M | -44.5% |
| FY2020 | -$24.3M | -342.8% |
| FY2019 | -$5.5M | +76.5% |
| FY2018 | -$23.4M | -4.3% |
| FY2017 | -$22.4M | +6.6% |
| FY2016 | -$24.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice